Peptide Knowledge Base · Cosmetic
Acetyl-Hexapeptide-8 (Argireline): what it is, what the evidence says, and its real status
A topical cosmetic peptide marketed as a 'Botox-like' expression-line softener, low-risk, well-established in skincare.
Short version: the topical 'Botox-in-a-jar' peptide your serum may already contain. Cosmetic-grade evidence, low risk, and legal as a topical, a clean top-of-funnel education entry.
Can you actually get it?
Plain-English verdict: Available (cosmetic).
Regulatory status: Legal (cosmetic, topical) · Cosmetic use.
Topical cosmetic use is available and well established. Acetyl-Hexapeptide-8 is a cosmetic ingredient with modest, low-risk topical evidence for softening expression lines. This entry covers topical cosmetic use only.
How does Acetyl-Hexapeptide-8 (Argireline) work?
A peptide proposed to modestly reduce muscle-contraction signaling at the skin surface, softening the appearance of expression lines.
What it does — and what it does not do
What it does: Used topically to soften the look of fine expression lines; low-risk and widely formulated.
What it does not do: It is not injectable Botox and not a wrinkle cure; topical effect sizes are modest.
How honest is the evidence?
Evidence grade C — cosmetic-grade topical evidence; modest effect sizes. Read our grading methodology for what each grade means.
What we still don't know: Topical penetration and real-world effect size vary by formulation; it is not a substitute for procedures.
WADA status: Not prohibited.
How it is taken
Per cosmetic formulation; topical only.
Who should not take it
Topical: generally well tolerated; patch-test for sensitivity.
Sources
Acetyl-hexapeptide-8 (Argireline) cosmetic-peptide literature
Compounded medications are not FDA-approved. We keep two signals separate and never collapse them: whether you can get something, and what the rule currently says. See the live FDA Peptide Tracker or the knowledge base.
Last reviewed 2026-08-11 · Peptós.LIFE · Not medical advice.